AKBA - AKEBIA THERAPEUTICS INC
This page shows which of the focused investors we track hold AKBA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2018 it was held by 2 managers with an aggregate reported value of $166.61M, which is 0.02% of the combined portfolio.
As of Q4 2018, 2 tracked institutional managers held AKBA (AKEBIA THERAPEUTICS INC) with an aggregate reported value of $166.61M — 0.02% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades AKBA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2018
- Ticker
- AKBA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Seth Klarman - Baupost Group | 1.17% | New | 24,471,453 | $135.33M |
| 2 | David Abrams - Abrams Capital Management | 1.29% | Add +405.4% | 5,656,462 | $31.28M |
Loading holder history for AKBA…